v3.25.2
Segment Reporting - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Revenue $ 102,692 $ 70,514 $ 189,807 $ 132,936
Reconciliations:        
Depreciation and amortization 2,286 1,712 4,458 3,454
Stock-based compensation 7,813 3,108 11,796 2,657
Gross profit 70,902 42,952 129,378 80,363
Operating Segments        
Segment Reporting Information [Line Items]        
Revenue 102,692 70,514 189,807 132,936
Adjusted cost of services 30,208 26,668 57,604 50,767
Adjusted gross profit 72,484 43,846 132,203 82,169
Other        
Segment Reporting Information [Line Items]        
Revenue 908 1,590 908 2,551
Adjusted cost of services 244 145 244 145
Adjusted gross profit 664 1,445 664 2,406
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment        
Reconciliations:        
Depreciation and amortization 1,389 808 2,464 1,624
Stock-based compensation 193 86 361 134
Restructuring costs     0 48
GeneDx        
Segment Reporting Information [Line Items]        
Revenue 101,784 68,924 188,899 130,385
GeneDx | Operating Segments        
Segment Reporting Information [Line Items]        
Revenue 101,784 68,924 188,899 130,385
Adjusted cost of services 29,964 26,523 57,360 50,622
Adjusted gross profit $ 71,820 $ 42,401 $ 131,539 $ 79,763